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Abstract
Background: Identification of homogenous subgroups of patients with low back pain (LBP) and classification-based treatment
have been recommended by some researchers and primary care clinicians. However, evidence regarding the effectiveness of this
approach is not conclusive; one reason for this controversy appears to be the heterogeneity of trials in this context.
Methods: The aim of this study was to determine the effectiveness of classification-specific physical therapy in patients with LBP. The
included trials were investigated in more homogeneous categories with respect to their classification scheme. Electronic databases
including Medline, Cochrane, Ovid, Scopus, and PEDro were searched systematically for English-language randomized controlled
trials (RCTs), published from 1980 to October 3, 2015. We included studies on LBP cases, which aimed to compare classification-
specific physical therapies with non-specific treatments lacking patient classification. PEDro scoring was used to check the quality
of the included trials, and the GRADE approach was used to evaluate the overall quality of evidence. Data on participants’ charac-
teristics, sample size, and inclusion/exclusion criteria were extracted to obtain an overview of the included RCTs.
Results: A total of 12 RCTs were identified and categorized into four classification schemes. Some evidence supporting classification-
specific treatment was found in each of the schemes. However, the reported evidence was conflicting predominantly due to differ-
ences in the study design. Also, GRADE quality assessment indicated the low quality of evidence for both approaches.
Conclusions: Categorization of trials based on their classification scheme to investigate the efficacy of classification-based physical
therapy could reduce the heterogeneity of trials and allow researchers to understand the contradictory results in this context.
Keywords: Classification, Low Back Pain, Physical Therapy, Sub-Group
1. Background
Low back pain (LBP) is a prevalent condition with con-
siderable negative effects on individuals, their families,
and society (1-4). LBP imposes an enormous annual fi-
nancial burden and causes disability around the world (5-
9). Considering its clinical importance, a large number of
studies have been dedicated to LBP over the past decades.
Despite great research considerations, it seems that there
are no significant clinical outcomes, and recurrent LBP
is still responsible for the considerable rise in healthcare
costs in the past two decades (10-12).
LBP continues to be a major disabling condition and
one of the four most common diseases worldwide (13). Re-
searchers and clinicians have tried to find ways to further
improve treatment effectiveness in individuals suffering
from LBP. In this regard, categorization of patients into
homogenous subtypes and use of classification-specific
treatment have gained increasing popularity over the past
decade. As suggested in many studies, identification of ho-
mogenous subgroups and classification-based treatment
can contribute to improved treatment outcomes in LBP
cases (14-22).
Despite the increasing development of classification
systems, there are arguments which reject the superior
outcomes of classification-specific treatment (23-25). Many
systematic reviews have attempted to study the effective-
ness of physical therapy interventions for subgroups of
LBP patients. However, no conclusive evidence suggests
that classification-based physical therapy interventions
are superior to non-subgrouped physical therapy treat-
ments.
One problem of systematic review and meta-analysis
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studies is the heterogeneity of the included trials. In fact,
the conflicting results reported in previous studies, inves-
tigating the efficacy of classification-specific treatment in
individuals with LBP, are attributed to the heterogeneity
of trials (26-28). Nevertheles, it is possible to present more
homogenous studies by categorizing trials based on their
classification scheme.
Today, numerous classification systems have emerged
for patients with LBP. Each system classifies LBP cases with
regard to different aspects and distinct purposes (29, 30).
Overall, movement is the core of physical therapy (31, 32),
and the movement system is the focus of physical therapy
profession; therefore, movement-based classifications are
particularly important in physical therapy.
Based on a study by Karayannis et al. (33), five
dominant movement-based classifications have been
identified, which address physical therapy treatment.
These classifications include mechanical diagnosis and
treatment (MDT), treatment-based classification (TBC),
pathoanatomic-based classification (PBC), movement sys-
tem impairment (MSI)-based classification, and O’Sullivan
classification system (OCS).
While a number of systematic reviews (27, 28, 34,
35) have evaluated the effectiveness of classification-based
physical therapy for LBP, controversial results in this con-
text are still a problem. Although this problem has been
to some extent attributed to heterogeneous trials on the
effectiveness of classification-specific physical therapy, the
issue of heterogeneity still remains as one of the serious
limitations of systematic review studies. Categorization of
trials based on their classification systems may somewhat
reduce the problem of heterogeneity. In particular, focus-
ing on movement-based classifications may be useful in
the field of physical therapy when investigating the effec-
tiveness of treatments.
To the best of our knowledge, no research has been so
far conducted on the effectiveness of classification-based
physical therapy for LBP with the purpose of reducing the
heterogeneity of trials through focusing on movement-
based classifications. With this background in mind, it
seems appropriate to perform a systematic review on the
effects of classification-based physical therapy on LBP in
comparison to physical therapy without a classification
scheme.
2. Objectives
This systematic review aimed to reduce the hetero-
geneity of clinical trials, investigating the efficacy of
classification-based physical therapy by grouping and re-
porting studies with main movement-based classification
schemes. This is an important issue as grouping of trials
based on their classification scheme has not been system-
atically carried out.
3. Data Sources
Medline, Cochrane, Ovid, Scopus, and PEDro electronic
databases were searched systematically to identify rel-
evant studies, using keywords and search terms built
around a population, intervention, comparison, outcome
(PICO) framework, as shown in Table 1 (36). The literature
search was limited to English-written RCTs, published from
1980 to October 3, 2015. Initially, titles and abstracts of po-
tentially relevant trials were checked, and both obviously
non-relevant and duplicate articles were eliminated (36).
Then, full-text copies of trials, which seemed to be relevant,
were retrieved and reviewed. Eventually, relevant articles
were selected according to the inclusion and exclusion cri-
teria. In addition, an extensive hand search of the refer-
ence lists of relevant systematic reviews and included ar-
ticles was performed to identify more studies.
Table 1. Population, Intervention, Comparison, and Outcomes (PICO) Framework
Population Low Back Pain
Interventions Classification-based treatment, classification-based
physical therapy, treatment in subgroups, subgrouping,
classification-guided treatment, and directional exercises
Comparison Stabilization exercises, manipulation, strengthening
exercises, usual physical therapy, control group,
comparison group, generic physical therapy, traditional
physical therapy, manual therapy, non-directional
exercises, and modalities
Outcomes Pain intensity, functional disability, quality of life, clinical
examination, duration of symptoms, medication use, and
kinematics
4. Study Selection
Articles were considered eligible if they were RCTs
comparing classification-based physical therapy with non-
specific, non-matched treatment in patients with LBP. Tri-
als were included if they focused on one or more of
five dominant movement-based classification systems (33).
RCTs were included if their target population included
subjects over 18 years of age with LBP as their primary
complaint. There was no limitation on the duration of
symptoms. Trials including subjects with primary lower
limb impairments, previous spinal surgery, spinal defor-
mity and fracture, systematic inflammatory diseases, preg-
nancy, ankylosing spondylitis, rheumatoid arthritis, se-
vere neurological deficiencies, spinal malignancy, osteo-
porosis, and other serious medical conditions were ex-
cluded.
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Two independent assessors evaluated the quality of
each trial, using the 10-item PEDro scale, as listed in Fig-
ure 1 (37); any disagreement on PEDro scores was resolved
through discussion (36). Finally, an expert confirmed the
selected articles to ensure the quality of included articles.
The PEDro scale is an 11-item scale, designed to assess the
methodological quality of RCTs in physical therapy (37).
The first item of PEDro scale, which is related to the
eligibility of trials and assesses external validity (37), was
not considered in scoring the trials in the present review,
similar to previous systematic reviews (27, 28, 38). Overall,
this scale is a 0 - 10 score measure in which trials with a
score of six or higher are considered to have a high qual-
ity, while those with a score of five or less are considered as
low-quality (23). The scale has been demonstrated to have
“fair” to “substantial” reliability (39). It is also a valid mea-
sure of the methodological quality of clinical trials (40).
5. Data Extraction
Two reviewers independently extracted the data on the
classification scheme, participants’ characteristics, sam-
ple size, treatment programs, outcome measures, and in-
clusion/exclusion criteria to obtain an overview of the in-
cluded RCTs (36). The sample sizes and standard deviations
for each primary outcome were extracted, as well. Data ex-
traction was performed as the reviewer was blinded to the
names of the authors, institutions, and journals in order to
minimize the risk of bias (36, 41).
5.1. Statistical Analysis
The Standardized Mean Difference (SMD) is used to cal-
culate the effect size of treatments. Use of SMD allows the
comparison of studies with different outcome measures
(36, 41). Treatment effects and 95% confidence intervals
(CIs) for continuous data were calculated, using Hedges’
adjusted g (SMD) (42). For dichotomous data, relative risk
and 95% CIs were calculated (42). Treatment effects favor-
ing classification-specific treatments were assigned posi-
tive SMD values. Values of 0.1, 0.2, 0.5, and 0.8 were re-
garded as trivial, small, moderate, and large effect sizes, re-
spectively (43).
In terms of continuous data, the sample size, mean,
and standard deviation were recorded for all primary out-
comes in the follow-ups for each group (44). If the mean
values were not provided, the medians were used to es-
timate the treatment effects (27, 44). If standard devia-
tions were not reported, the standard errors of mean val-
ues were used to calculate the standard deviations (44).
Similarity between the trials was not sufficient to con-
duct a meta-analysis. However, a qualitative analysis was
performed, using the GRADE approach. This approach was
used to qualitatively determine the grade of evidence for
primary outcome measures (45). Five domains were con-
sidered for judgment: limitations, inconsistency, indirect-
ness, imprecision, and publication bias. The overall quality
of evidence was determined, considering the combination
of these elements for primary outcome measures. Over-
all, four levels of evidence quality have been recommended
by the GRADE Working Group, which are as follows (36, 45,
46):
- High-quality evidence: At least 75% of RCTs, regardless
of the study design, have consistent findings, direct and
precise data, and no known or suspected publication bi-
ases. Further research is very unlikely to change our con-
fidence in the estimate of the effect.
- Moderate-quality evidence: One of the domains is not
met. Further research is likely to have an important impact
on our confidence in the estimate of the effect and may
change it.
- Low-quality evidence: Two of the domains are not met.
Further research is very likely to have an important impact
on our confidence in the estimate of the effect and is likely
to change it.
- Very-low-quality evidence: Three of the domains are
not met. Any estimate of the effect is very uncertain.
6. Results
A total of 5,436 papers were retrieved through search-
ing Medline, Embase, Cochrane, Ovid, Scopus, and PEDro
databases, and 14 papers were found via hand searching.
The search strategy, which led to the acquisition of 12 RCTs
(15, 18, 20, 23, 47-54), is depicted in Figure 2. The kappa
value was 0.65 (P = 0.02), which indicates substantial agree-
ment between the reviewers. Six out of all 12 trials (15, 48,
51-54) scored five or below and were categorized as low-
quality studies, using the PEDro scale. The other six trials
(18, 20, 23, 47, 49, 50) scored six or higher and were con-
sidered as high-quality studies (Table 2). A qualitative anal-
ysis was performed using the GRADE system for primary
outcome measures. Further details on the GRADE quality
assessment of all primary outcome measures are summa-
rized in Appendix 1 in the supplementary file.
6.1. Trial Characteristics
Key trial characteristics and outcomes are summarized
and outlined in Table 3 are described below.
6.1.1. Trials Applying Mechanical Diagnosis and Treatment
(MDT)
According to our literature review, two trials (20, 50) fo-
cused on MDT. One trial (20) (N = 230, PEDro: 7/10), which
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1.  Eligibility criteria were specified  No  Yes   
2.  Subjects were randomly allocated to groups  No  Yes   
3.  Allocation was concealed  No  Yes   
4.  The groups were similar at baseline regarding the most important prognostic   
indicators  
No  Yes   
5.  There was blinding of all subjects  No  Yes   
6.  There was blinding of all therapists who administered the therapy  No  Yes   
7.
 
There was blinding of all assessors who measured at least one key outcome 
 No
 
Yes  
 
8.  Measures of at least one key outcome were obtained from more than 85% of the  
 subjects initially allocated to groups  
No  Yes   
9.  All subjects for whom outcome measures were available received the treatment   
or control condition as allocated or, where this was not the case,  data for at least 
one key outcome was analyzed by “intention to treat”   
No  Yes   
10.  The results of between-group statistical comparisons are reported for at least  
one key outcome  
No  Yes   
11.   The study provides both point measures and measures of variability for at  least 
 one key outcome  
No  Yes   
Note: Items 2 to 11 were used for scoring  
Figure 1. The PEDro Scale
studied acute, subacute, and chronic LBP, evaluated func-
tion and pain as the primary outcome measures at short-
term follow-up. They showed that MDT-matched treatment
significantly improved all primary and secondary out-
comes, compared to the evidence-based approach. Large
effect sizes were reported for back pain alleviation (SMD:
0.8, 95% CI: 0.3 - 1.2), moderate effect sizes for leg pain re-
lief (SMD: 0.7, 95% CI: 0.3 - 1.2) and function improvement
(SMD: 0.5, 95% CI: 0.0 - 1.0), and small effect sizes for medi-
cation use reduction (SMD: 0.4, 95% CI: 0.0 - 1.0) in favor of
matched treatment at short-term follow-up.
Another trial (50) (N = 259, PEDro: 6/10), which stud-
ied acute and subacute LBP, showed that MDT intervention,
along with recommendations on back care, was slightly
more effective than manipulation treatment in cases with
LBP (experiencing more than six weeks of pain) at all short,
intermediate, and long-term follow-ups. There was a sta-
tistically significant difference in primary outcome mea-
sures, including the patient proportion with successful
function (Roland Morris disability questionnaire; RMDQ),
which was higher in the MDT intervention group at two-
month follow-up. In addition, a statistically significant
difference was observed in most secondary outcome mea-
sures. A small effect size was reported for the patient popu-
lation reporting success on RMDQ as the primary outcome
measure (SMD: 0.3, 95% CI: 0.0 - 0.5) at short-term follow-
up, thus indicating the superiority of MDT over manipula-
tion.
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5,436 Records identified through
searching databases
14 Additionl records identified
through hand searching
3,268 Articles identified after 2,182
duplicates removed
3,268 Articles screened
by title and abstract
3,194 Articles excluded
74 Full text articles
evaluated for eligibAity
12 TriaIs included
 62 Full-text articles excluded
Reasons for exclusion:
 -25 Were not RCTs
 -19 Did not compare classification-
 based physical therapy with
 unspecific non-matched treatment
 without subgrouping
 -12 Were not physiotherapy
 movement-based classification
 -6 Were not Engish language artides
Figure 2. The Flow Diagram Depicting the Research Process
Table 2. Assessment of the Methodological Quality of Studies Using the Pedro Scale
Trials
PEDro
items
Apeldoorn
et al.
(2012) (23)
Brennan
et al.
(2006) (15)
Browder
et al.
(2007) (47)
Vibe
Fersum et
al. (2013)
(54)
Fritz et al.
(2003)
(48)
Henry et
al. (2014)
(49)
Hoffman
et al.
(2011) (18)
Long et al.
(2004)
(20)
Petersen
et al.
(2011) (50)
Saner et
al. (2015)
(51)
Saner et
al. (2016)
(52)
Sheeran et
al. (2013)
(53)
Total
2 1 1 1 1 1 1 1 1 1 1 1 1 12
3 0 0 1 1 0 1 0 1 1 0 0 1 6
4 0 0 1 0 0 1 1 1 1 0 0 0 5
5 1 0 0 0 0 0 0 0 0 0 0 0 1
6 0 0 0 0 0 0 0 0 0 0 0 0 0
7 1 0 0 0 1 0 1 0 0 0 0 0 3
8 1 1 0 0 0 1 1 1 0 1 1 1 8
9 1 1 1 1 1 1 0 1 1 1 1 0 10
10 1 1 1 1 1 1 1 1 1 1 1 1 12
11 1 1 1 1 1 1 1 1 1 1 1 1 12
Total 7 5 6 5 5 7 6 7 6 5 5 5 69
To sum up, moderate-quality evidence has been re-
ported in one trial (imprecision), indicating that matched
MDT-based treatment is more effective than non-matched
evidence-based care for patients with LBP at short-term
follow-ups. Further research is likely to have an impor-
tant impact on our confidence in the estimate of the ef-
fect and may change it. Also, moderate-quality evidence re-
ported in one trial (imprecision) suggests that MDT-based
treatment, matched to patient subgroups, is more effective
than manipulation treatment non-matched to LBP sub-
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types at intermediate-term follow-ups. Further research is
likely to have an important impact on our confidence in
the estimate of the effect and may change it.
6.1.2. Trials Applying O’Sullivan Classification System (OCS)
Four trials (51-54) focused on the OSC scheme. One trial
(54) (N = 121, PEDro: 5/10) compared classification-based
cognitive functional therapy with traditional manual ther-
apy and exercise in chronic cases of LBP at short- and long-
term follow-ups; pain and function were the primary out-
come measures. They found statistically and clinically sig-
nificant differences in favor of classification-based treat-
ment in terms of all outcomes in both post-treatment and
12-month follow-ups.
In these studies, large effect sizes were evident for func-
tion improvement at short-term (SMD: 1.4, 95% CI: 1.0 - 1.9)
and long-term (SMD: 0.9, 95% CI: 0.4 - 1.3) follow-ups, favor-
ing classification-based treatment. Large effect sizes were
reported for pain alleviation at short-term follow-up (SMD:
1.1, 95% CI: 0.7 - 1.6), while moderate effect sizes were ob-
served at long-term follow-up (SMD: 0.7, 95% CI: 0.2 - 1.1) in
favor of classification-based treatment.
Another trial (53) (N = 58, PEDro: 5/10) attempted to
compare classification-specific postural intervention with
general postural intervention at short-term follow-up. This
study showed significant statistical and clinical differ-
ences in function as a primary outcome measure, as well
as most secondary outcome measures after four weeks
of home exercise in patients with non-specific LBP. Large
effect sizes were reported for function improvement at
short-term follow-up (SMD: 1.0, 95% CI: 0.4 - 1.6), indicating
the superiority of classification-specific postural interven-
tion over general postural intervention.
In addition, a trial (52) (N = 106, PEDro: 5/10) investi-
gated the short-term results of a tailored specific exercise
program in comparison with a general exercise program
in cases with sub-acute or chronic LBP and impaired move-
ment control. Neither of treatment approaches resulted in
a significant difference in the recovery measured by func-
tion (patient-specific functional scale; PSFS) as the primary
outcome. A small effect size was reported for function im-
provement at short-term follow-up (SMD: 0.3, 95% CI: 0.0 -
0.7) in favor of movement control over general exercise.
In another study (51) (N = 106, PEDro: 5/10), tai-
lored specific exercise was compared with a general exer-
cise program in non-specific LBP patients with impaired
movement control at short-, intermediate-, and long-term
follow-ups. They found no statistically significant inter-
group difference in functional improvement (PSFS) as the
primary outcome or any of the secondary outcome mea-
sures. A negative effect size was found for functional im-
provement at short-term follow-up (SMD: -0.1, 95% CI: -0.5 -
0.2), and no effect was observed at intermediate (SMD: 0.0,
95% CI: -0.4 - 0.3) and long-term (SMD: 0.0, 95% CI: -0.4 - 0.3)
follow-ups in favor of tailored specific exercise versus gen-
eral exercise.
To sum up, there is low-quality evidence from two
trials (indirectness due to clinical heterogeneity, limita-
tion imposed by high risk of bias), indicating that OSC-
based classification-specific treatment is more effective
than other treatment programs without a classification
scheme for chronic LBP cases at short-term follow-up. Fur-
ther research is highly likely to have an important impact
on our confidence in the estimate of the effect and is likely
to change it.
One trial reported statistically significant differences
in the outcomes in favor of OSC-based classification-
specific treatment at long-term follow-up. There is
moderate-quality evidence from two trials (limitation
due to the high risk of bias), indicating no statistically
significant difference in function (PSFS) as a primary out-
come measure at short-term follow-up between subacute
and chronic LBP cases who received OSC-based movement
control exercises and general exercise treatment. Further
research is likely to have an important impact on our
confidence in the estimate of the effect and may change it.
Also, long-term follow-up was conducted in one trial and
showed no statistically significant difference in any of the
follow-ups.
6.1.3. Trials Applying Treatment-Based Classification (TBC)
Overall, five trials (15, 23, 47-49) focused on the TBC
scheme. One trial (48) (N = 78, PEDro: 5/10) targeting acute
LBP compared TBC-specific treatment with clinical prac-
tice guidelines. After four weeks, most outcome measures
showed statistically significant inter-group differences in
favor of TBC approach, although there was no statistically
significant difference after a one-year follow-up. Moderate
effect sizes were reported for mental health improvement
(SMD: 0.7, 95% CI: 0.2 - 1.1), function improvement (SMD: 0.5,
95% CI: 0.0 - 1.0), physical health progress (SMD: 0.5, 95% CI:
0.0 - 1.0), physical impairment reduction (SMD: 0.4, 95% CI:
-0.4 - 1.4), and return to work (SMD: 0.6, 95% CI: 0.1 - 1.2),
while no effect on patient satisfaction (SMD: 0.0, 95% CI: -
0.6 - 0.4) was reported at short-term follow-up in favor of
TBC-based classification-specific treatment.
In the mentioned study, small effect sizes were re-
ported for improving mental health (SMD: 0.3, 95% CI: -0.1 -
0.8) and physical health status (SMD: 0.2, 95% CI: -0.1 - 0.7),
while trivial effect sizes were found for functional improve-
ment (SMD: 0.1, 95% CI: -0.3 - 0.5) at long-term follow-up, fa-
voring TBC-based classification-specific treatment.
Another trial (15) (N = 123, PEDro: 5/10) investigated
modified TBC-based matched treatment versus TBC-based
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non-matched intervention in patients with acute and sub-
acute LBP, using function as the only outcome measure.
This study showed that matched treatment could lead to a
statistically significant functional improvement (Oswestry
Disability Index; OSW) at short-term and one-year follow-
ups. A small effect size was evident for functional improve-
ment at short-term follow-up (SMD: 0.3, 95% CI: 0.0 - 0.6),
and a trivial effect size was observed at long-term follow-up
(SMD: 0.1, 95% CI: -0.2 - 0.6), favoring matched treatment.
Another trial (47) (N = 48, PEDro: 6/10) compared
an extension-specific exercise program with abdominal
strengthening exercises in a population suggested to ben-
efit from an extension-oriented treatment approach; pain
and function were considered as the primary outcome
measures. The results showed that function (OSW) signif-
icantly changed at short- and intermediate-term follow-
ups in favor of the extension-oriented treatment approach.
Pain (numeric pain rating scale; NPRS) showed a signifi-
cant difference within only one week, but not at longer
follow-ups.
In the above-mentioned study, small effect sizes were
found at short-term follow-ups for pain reduction within
one week (SMD: 0.4, 95% CI: -0.2 - 1.0) and four weeks (SMD:
0.3, 95% CI: -0.3 - 0.9), as well as function improvement
at one week (SMD: 0.3, 95% CI: -0.3 - 0.8). Also, a moder-
ate effect size was reported for function improvement at
four-week follow-up (SMD: 0.6, 95% CI: 0.1 - 1.2) in favor
of extension-specific exercises. A moderate effect size was
evident for function improvement at intermediate-term
follow-up (SMD: 0.7, 95% CI: 0.1 - 1.3), favoring extension-
specific exercises. Additionally, a small effect size was re-
ported for pain alleviation at intermediate-term follow-up
(SMD: 0.2, 95% CI: -0.3 - 0.8), favoring extension-specific ex-
ercises.
Another trial (23) (N = 156, PEDro: 7/10) attempted to
compare modified TBC with usual physical therapy in sub-
acute and chronic LBP patients. They found no significant
inter-group differences in primary outcome measures in-
cluding pain, function, and global perceived effect (GPE) or
secondary outcomes at any of the short, intermediate, or
long-term follow-ups. Negative effect sizes were reported
for function (SMD: -0.2, 95% CI: -0.5 - 0.1) and pain (SMD: -0.3,
95% CI: -0.7 - 0.0) and a zero effect size for GPE (SMD: 0.0, 95%
CI: -0.3 - 0.3) at short-term follow-up in favor of TBC-based
intervention.
In the discussed study, there were small effect sizes for
function improvement (SMD: 0.2, 95% CI: -0.2 - 0.6), zero ef-
fect for pain alleviation (SMD: 0.0, 95% CI: -0.4 - 0.4), and
negative effect size for GPE (SMD: -0.2, 95% CI: -0.6 - 0.1)
at intermediate-term follow-up. Long-term effect size was
zero for pain alleviation (SMD: 0.0, 95% CI: -0.3 - 0.5), small
for function improvement (SMD: 0.3, 95% CI: 0.0 - 0.8), and
moderate for GPE (SMD: 0.5, 95% CI: 0.1 - 0.9) in favor of TBC-
based intervention.
In a recent trial (49) (N = 124, PEDro: 7/10), the
TBC scheme was used jointly with the MSI approach.
The researchers observed no further improvement in
classification-matched treatment in comparison with
classification-unmatched treatment, using pain and func-
tion as the primary outcome measures. Further details are
provided in the section, “trials applying movement system
impairment”. Negative effect sizes were found for func-
tional improvement (SMD: -0.3, 95% CI: -0.8 - 0.1) and pain
alleviation (SMD: -0.1, 95% CI: -0.5 - 0.3) at intermediate-
term follow-up. At long-term follow-up, a negative effect
size was found for pain alleviation (SMD: -0.2, 95% CI: -0.7
- 0.1) and zero effect size for function improvement (SMD:
0.0, 95% CI: -0.5 - 0.3) in classification-specific treatment
versus non-specific treatment.
To sum up, there is low-quality evidence from three
trials (indirectness due to clinical heterogeneity and lim-
itations due to the high risk of bias), indicating that TBC-
based specific treatment is more effective in improving
short-term outcomes than non-specific treatment. Further
research is very likely to have an important impact on our
confidence in the estimate of the effect and is likely to
change it.
In a previous trial, an intermediate-term follow-up was
performed and a significant difference was observed in
favor of TBC. Two other trials collected data at long-term
follow-ups, as well. However, one supported the persis-
tence of the benefits of TBC at long-term follow-up, while
the other did not. Moderate-quality evidence from these
two trials (indirectness due to the simultaneous use of
MSI scheme with TBC and clinical heterogeneity) indicates
no statistically significant difference at any of the follow-
ups for primary outcome measures between LBP cases who
received TBC-based specific treatment and those who re-
ceived non-matched treatment. Further research is likely
to have an important impact on our confidence in the esti-
mate of the effect and may change it.
6.1.4. Trials Applying Movement System Impairment (MSI)
Scheme
According to our literature review, two trials (18, 49)
focused on the MSI scheme. One trial (18) (N = 36, PEDro:
6/10) compared MSI-based classification-specific treatment
with a common non-specific therapy in chronic LBP cases
at short-term follow-up. A statistically significant decline
in lumbopelvic rotation and the amount of hip rotation be-
fore the start of pelvic movement was detected in the spe-
cific approach, which indicates the improvement of move-
ment pattern following treatment. Large effect sizes were
reported for all outcome measures including lumbopelvic
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range of motion (ROM) during lateral hip rotation (SMD:
1.6, 95% CI: 0.7 - 2.4), lumbopelvic ROM during medial hip
rotation (SMD: 1.6, 95% CI: 0.8 - 2.5), lateral hip rotation ROM
(SMD: 0.9, 95% CI: 0.1 - 1.6), lateral hip rotation completed
before the onset of lumbopelvic rotation (SMD: 0.9, 95% CI:
0.1 - 1.6), and medial hip rotation completed before the on-
set of lumbopelvic rotation (SMD: 1.2, 95% CI: 0.4 - 2.0), fa-
voring MSI-based classification-specific treatment.
In addition, another trial (49) (N = 124, PEDro: 7/10)
compared classification-matched intervention with
classification-unmatched intervention, based on both MSI
and TBC schemes in chronic LBP patients. There was not a
statistically significant inter-group difference in pain and
disability scores as the primary outcome measures after
seven-week and one-year follow-ups. Negative effect sizes
were reported for functional improvement (SMD: -0.3, 95%
CI: -0.8 - 0.1) and pain relief (SMD: -0.1, 95% CI: -0.5 - 0.3)
at intermediate-term follow-up. At long-term follow-up,
a negative effect size was found for pain reduction (SMD:
-0.2, 95% CI: -0.7 - 0.1), and zero effect size was observed for
function improvement (SMD: 0.0, 95% CI: -0.5 - 0.3) in favor
of classification-specific treatment versus non-specific
treatment.
To sum up, moderate-quality evidence from one trial
(imprecision) indicates that MSI-based, classification-
specific treatment is more effective than non-specific
treatment for chronic LBP cases at short-term follow-up.
Further research is likely to have an important impact
on our confidence in the estimate of the effect and may
change it. Low-quality evidence from one trial (indirect-
ness due to the simultaneous use of TBC scheme with
MSI, imprecision) suggests no statistically significant
difference at intermediate and long-term follow-ups for
pain and function as the primary outcome measures be-
tween chronic LBP cases who received matched treatment
based on MSI and TBC schemes and those who received
unmatched intervention. Further research is likely to have
an important impact on our confidence in the estimate of
the effect and is likely to change it.
7. Conclusions
In this systematic review, we focused on movement-
based classification systems to investigate the effective-
ness of classification-specific physical therapy. We tried to
reduce the heterogeneity of the included trials by group-
ing studies based on the applied classification system. It
was not possible to perform a meta-analysis due to clinical
heterogeneity of the included trials.
7.1. Mechanical Diagnosis and Treatment (MDT)
Despite the differences in study design, two high-
quality trials supported the superiority of classification-
specific treatment. However, long-term effects of treat-
ment were evaluated in only one study, and further evi-
dence is required to confirm the durability of treatment ef-
fects. The effectiveness of treatment targeted to subgroups
using MDT has been supported in most previous system-
atic reviews (55, 56). These studies have suggested short-
term effects for MDT treatment, as shown in the present
study. Our findings in this systematic review are consistent
with previous studies.
7.2. O’Sullivan Classification System (OCS)
Among four studies focusing on OSC (51-54), three tri-
als (51, 52, 54) were similar in terms of most characteris-
tics. However, two studies by Saner et al. (51, 52) were in
conflict with the study by Vibe Fersum et al. (54). In the
study by Vibe Fersum et al. (54), further improvements
in the classification-based approach might be attributed
to the strong emphasis on the cognitive aspects of multi-
dimensional treatment for chronic non-specific LBP cases
with special attention to patients’ LBP awareness and the
related signs and symptoms. Given the fact that the mecha-
nism of chronic LBP is behavioral and cognitive rather than
sensory and biomechanical (57), the greater emphasis of
the study by Vibe Fersum et al. (54) on the cognitive aspects
of treatment might have contributed to the superior out-
comes in classification-based intervention.
In addition, giving particular importance to patient
awareness and active participation in cognitive and behav-
ioral therapy may provide continuous treatment for pa-
tients in all aspects of life and can be a reason for greater
improvements observed in the classification-based treat-
ment in this study. Moreover, Vibe Fersum et al. (54) used
OSW to measure function as the primary outcome mea-
sure, whereas Saner et al. (51, 52) used PSFS. However, the
OSW questionnaire was reported to be more responsive
than PSFS in cases with subacute or chronic LBP and mild
disability (58). The trial by Sheeran et al. (53) confirmed
the superiority of classification-based treatment, although
their study specifically targeted postural training interven-
tion for chronic LBP patients. Overall, further studies are
needed to obtain more information in this context.
According to the GRADE approach, which assesses the
quality of evidence, further high-quality trials are recom-
mended to reveal the effectiveness of classification-specific
treatment, using the OSC scheme. To the best of our
knowledge, no previous systematic review has critically ap-
praised clinical trials, focusing on OSC scheme to deter-
mine the efficacy of OSC in the treatment of LBP.
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7.3. Treatment-Based Classification (TBC)
The conflicting results in trials investigating the effi-
cacy of TBC scheme may be attributed to differences in
the study designs; the main difference is the study popu-
lation characteristics. Three trials (15, 47, 48) included sub-
jects in the acute stage of LBP, while two trials (23, 49) eval-
uated participants with chronic LBP. Interestingly, trials
investigating acute LBP patients reported improvements
in matched treatment in comparison with non-matched
treatment. However, trials including more chronic par-
ticipants did not observe any superiority for the matched
treatment program. This can be explained by the fact that
TBC scheme is designed primarily to examine acute LBP pa-
tients, and the treatment approach is specifically applied
for cases of acute-stage LBP (59).
In addition, chronic pain is a complex phenomenon
and a multi-mechanism disorder, which cannot be strictly
attributed to the physical dimension (60-64). However,
it can be considered a complex interactive system, con-
sisting of multiple elements including physical, neuro-
muscular, psychosocial, cognitive, and behavioral com-
ponents and the interaction of elements influencing LBP
(60, 65). Two trials which included chronic LBP patients
did not consider multiple elements of chronic LBP in the
classification-based treatment program.
There is also controversy over the persistence of the su-
periority of classification-specific treatment at long-term
follow-up between trials conducted by Fritz et al. (48) and
Brennan et al. (15). This may be due to the fact that the sam-
ple size in the study by Fritz and colleagues was not large
enough to provide sufficient power for exhibiting the long-
term effects.
Considering the GRADE system of evidence quality, fur-
ther studies are recommended in order to estimate the ef-
fects of TBC scheme in people with LBP. Evidence on the ef-
ficacy of TBC scheme has been conflicting. This is in con-
sistence with previous reviews investigating the efficacy of
TBC in LBP cases. While some reviews have recommended
TBC as an approach for more effective interventions, others
have not.
The results of a study by Kent et al. noted that TBC-
based treatment targeted to subgroups may improve the
outcomes, although more extensive research is required
(66). Another review study noted that appropriate man-
agement of LBP via TBC reduces pain and disability in ath-
letes (55). Overall, further homogeneous studies can pro-
vide higher quality evidence and more explicit conclusions
on the effects of treatment.
7.4. Movement System Impairment (MSI) Scheme
The two trials focusing on the MSI scheme (18, 49) are al-
most similar. The contradictory results may be attributed
to differences in the outcome measures. Actually, chronic
LBP is a problem, consisting of more than one dimension.
Hence, it is ideal for researchers to consider multiple as-
pects of chronic LBP while assessing the outcomes of treat-
ment (67-69). Hoffman et al. (18) confined the evaluation of
treatment success to the improvement of physical impair-
ments, whereas Henry et al. (49) used pain, function, fear-
avoidance beliefs, and health status to evaluate the treat-
ment outcomes.
Researchers have been recommended to consider
more comprehensive outcomes to further reveal the treat-
ment effects (67, 70). Furthermore, in a study by Hoffman
et al. (18), medial and lateral hip rotations in the prone po-
sition were used as the treatment and also outcome mea-
sures. This could be a reason for the emergence of positive
effects in the classification-specific treatment.
In addition, different follow-up time points in the con-
ducted studies may be another reason for the contradic-
tory results. Conflicting evidence was reported by two tri-
als comparing MSI-based, classification-specific treatment
with non-matched treatment, disregarding the specific
characteristics of subgroups. Overall, further homoge-
neous studies are needed to reach a more accurate conclu-
sion on this scheme. It should be noted that there are no
previous systematic reviews investigating the effectiveness
of MSI-based classification treatment.
One limitation of this study was the heterogeneity of
trials, due to which it was not possible to conduct a meta-
analysis; however, a qualitative GRADE analysis was per-
formed. We could provide more homogeneous informa-
tion by investigating the trials in four categories, based on
their classification scheme. Another study limitation was
the exclusion of non-English language trials. In fact, it is
not clear whether or not the language limitation is associ-
ated with bias in this review.
The major strengths of this study include the novel
topical research question, use of best-practice system-
atic review methods including PICO, PEDro, PRISMA, and
GRADE, extensive literature search, and use of two inde-
pendent raters. Overall, grouping of trials based on the
classification system in the present study provides more
homogenous information to investigate the efficacy of
classification-specific physical therapy in LBP cases. In ad-
dition, it could resolve some controversies in studies in-
vestigating the effectiveness of classification-specific phys-
ical therapy and provided possible explanations for these
controversies. To come to a stronger conclusion about the
effectiveness of classification-based specific physical ther-
apy, further high-quality RCTs with more homogenous de-
signs are needed.
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Table 3. Characteristics of the Trials
RCTs Participants Interventions Comparison Interventions Outcome Measures and Follow-Up Terms
Fritz et al. (48),
CS: TBC, PEDro:
5/10
N = 78
Specific treatment matched to subgroups: -
Manipulation and mobilization techniques for lumbar
or SI joints. - Specific exs including flex exs for patients
with ext pattern and ext exs for patients with flex
patterns. - Stabilization and strengthening exs. -
Mechanical or self-traction (2-3 treatment sessions per
wk).
Guideline-based treatment involving aerobic exs
(treadmill walking or cycling), followed by general
muscle conditioning exs after 2 wk, as well as
instructions for patients to remain active as much as
possible (2-3 treatment sessions per wk).
- Clinical examination (impairment index), pain (NPRS),
function (modified OSW), health status (SF-36),
depression (CES-CD), fear- avoidance beliefs
questionnaire (FABQ), patient satisfaction, return to
work, and medical costs. - Short-, intermediate-, and
long-term follow-ups (4 wk, 6 mo, and 1 y)
Inclusion criteria:
Work-related LBP
with/without
sciatica, duration
of pain < 3 wk, and
sufficient severity
of LBP to
necessitate
modified work
duties.
Subgroups:
Mobilization,
Specific exs,
Immobilization,
Traction
Long et al. (20),
CS: MDT, PEDro:
7/10
N = 230 McKenzie treatment matched to the patient’s DP
including recommendations and unidirectional
end-range exs for the lumbar region according to the
signs and symptoms (3 - 6 sessions over 2 wk).
McKenzie recommendations and unidirectional
end-range lumbar exs opposite to the patient’s DP (3-6
sessions over 2 wk). Evidence-based care consisting of
multidirectional, mid-range lumbar exs, hip and thigh
muscle stretching, and some treatment
recommendations (3-6 sessions over 2 wk).
- Primary outcome measures: Pain (VAS), function
(RMDQ), and medication use. - Secondary outcome
measures: Activity interference (BDI), pain site,
neurological status (QTFQ), patient satisfaction, return to
work, and leisure activities. - Short-term follow-up at 2
wk.
Inclusion criteria:
Age of 18 - 65 y, LBP
(acute, subacute,
and chronic)
with/without leg
symptoms,
with/without one
neurological sign,
and presence of
directional
preference.
Subgroups: Ext DP,
Flex DP, Lateral DP
Brennan et al.
(15), CS: Modified,
TBC PEDro: 5/10
N = 123
Interventions matched to subgroups including one of
the following treatment programs: - Manipulation for
the lumbosacral region and alternating lumbar flex and
ext exs in the quadruped position. - Specific exs including
repeated flex or ext exs, based on the patient’s preference
and sign/symptom responses to different positions and
movements. - Stabilization and strengthening exs for
oblique abdominal muscles (twice weekly over 4 wk). In
the subacute stage, a general aerobic exs program was
applied with regard to the treatment group.
Interventions unmatched to subgroups including one of
the manipulation techniques, specific exs or trunk
stabilization, and a strengthening exs program (twice
weekly for 4 wk). Treatment progression in the subacute
stage involved a general aerobic exs program unmatched
to the treatment group.
- Function scale (OSW). - Short- and long-term follow-ups
(4 wk and 1 y)Inclusion criteria:
Age of 18-65 y,
primary
complaint of LBP,
with/without
extension into the
lower extremity,
pain duration
(acute/subacute) <
90 d, and an OSW
score of≥ 25%.
Subgroups:
Specific exs,
Manipulation,
Stabilization
Browder et al.
(47), CS: TBC,
PEDro: 6/10
N = 48
Ext-oriented treatment approach: An exs program and
mobilization techniques to centralize the symptoms. Exs
included repeated lumbar ext in the prone position
progressing to the standing position and repeated
end-range ext exs (three sets of 10 repetitions with
holding each repetition 2-3 s at end-range). Mobilization
treatment including posterior-anterior lumbar
mobilization (10 to 20 repetitions). Home exs, including
one set of 10 repetitions every 2 to 3 walking hours (Six
sessions over 4 wk).
A strengthening program with the aim of increasing
isolated muscle contraction of deep abdominal muscles
and increasing the muscle strength of primary lumbar
stabilizers (six sessions for 4 wk)
- Primary outcome measures: Function (OSW) and pain
(NPRS). - Secondary outcome measures: Fear-avoidance
beliefs (FABQ). - Short and intermediate follow-ups (1 wk,
4 wk, and 6 mo).
Inclusion criteria:
Age of 18-60 y, LBP
and symptoms of
any duration, pain
extended distal to
the buttocks in at
least one lower
extremity,
presence of the
centralization
phenomenon, and
modified OSW
score≥ 30%.
Subgroups: - Ext
pattern specific
exs
Hoffman et al.
(18), CS: MSI,
PEDro: 6/10
N = 36
MSI classification-based treatment: Enhancement of
patients’ knowledge regarding their specific LBP
classification and painful positions/movement
directions in order to minimize faulty postures and
movements in daily activities and prescription of specific
exs to minimize painful postures and movement
directions in the lumbopelvic region during daily
activities (6 sessions weekly over 6 wk).
Non-specific treatment including patient knowledge
enhancement of the spine, neutral spinal alignment, and
LBP, as well as patient education regarding the
maintenance of neutral spinal alignment during painful
daily activities (6 sessions weekly over 6 wk).
- Kinematics of prone medial and lateral hip rot. -
Short-term follow-up (1 wk).Inclusion criteria:
Age of 18 - 60 y, LBP
(chronic) for≥ 12
mo, and no acute
flare-up.
Subgroups: Rot,
Rot with ext
Petersen et al.
(50), CS: MDT,
PEDro: 6/10
N = 259
McKenzie treatment program: - Recommendations for
back self-care provided in an educational booklet. -
Instructions on proper back care and maintenance of
physical activity. Vertebral mobilization techniques
including manipulation thrusts were not applied (max
of 15 sessions over 12 wk). If necessary, a home-based
strengthening and stabilization exc program was
applied at the end of the clinical treatment for a duration
of 2 mo.
Spinal manipulation involving manual therapy
techniques, such as mobilization and manipulation of
the spine, massage of myofascial trigger points,
stretching techniques, and lumbar flex and ext
movement exs. Specific exs in the DP of patients were
prevented. Guide to proper back care and maintaining
physical activity was presented (max of 15 sessions over 12
wk). If necessary, 2 mo of home strengthening and
stabilization exs were recommended at the end of the
clinical treatment period.
- Primary outcome measure: Proportion of patients
reporting success at 2-mo follow-up on the modified
RMDQ. - Secondary outcome measures: Success at 6 mo
and 1 y follow-ups on the RMDQ, pain control (back and
leg pain questionnaire), GPE, quality of life (SF-36), days
with reduced activity, return to work, satisfaction with
treatment, and use of health care after the completion of
treatment. - Short-, intermediate-, and long-term
follow-ups (after treatment and at 6 mo and 1-y).
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Inclusion criteria:
Age of 18-60 y,
non-specific LBP
(acute and
subacute) > 6 wk
with/without leg
pain, and presence
of disc-related
symptoms with
centraliza-
tion/peripheralization
of symptoms
(presence of
directional
preferences).
Classification:
-Centralizers,
-Peripheralizers
Apeldoorn et al.
(23), CS: Modified,
TBC PEDro: 7/10
N = 156
Direction-specific exs: Exs matched to specific DPs of the
patient. Manipulation: Manipulation thrusts for lumbar
and/or SI joints. Stability: Maintenance of spinal stability
during trunk and limb movements in different positions
and functional activities. Specific treatment lasted for a
min over 4 wk. Afterwards, treatment changed to current
Dutch LBP guidelines.
A usual physical therapy intervention consisting of
individual treatments, based on the clinical presentation
of the patient. The most common techniques were
muscle strengthening, mobilization and manipulation,
stabilization exs, massage therapy, and cognitive therapy.
- Primary outcome measures: Pain (NPRS), function
(OSW), and GPE. - Secondary outcome measures:
Fear-avoidance beliefs (FABQ), Orebro Musculoskeletal
Pain Questionnaire, and health status questionnaire
(SF-36). - Short-, intermediate-, and long-term follow-ups
(8, 26, and 52 wk after the start of treatment).
Inclusion criteria:
LBP with/ without
the associated leg
pain, age of 18 - 65
y, and current
episode duration
(subacute and
chronic) > 6 wk.
Subgroups: -
Specific exs,
-Manipulation,
-Stabilization
Vibe Fersum et al.
(54), CS: OCS,
PEDro: 5/10
N = 121
Classification-based cognitive functional therapy
consisting of four main components: - Patient’s cognitive
awareness regarding the viscous cycle of pain and how to
break it. - Specific exs to change old provocative motor
behaviors in order to normalize movement behaviors
guided by LBP classifications. - A function-integrated exs
program along with correcting movement behaviors in
provocative tasks of daily life. - Patient’s preference of
physical exs according to the LBP classification. The first
2-3 sessions were held weekly, followed by one session
every 2–3 wk over 12 wk.
Manual therapy and exs involving joint
mobilization/manipulation techniques for the
spine/pelvis. General exs at home or clinic or motor
control exs (treatment duration of 12 wk).
- Primary outcome measures: Function (OSW) and pain
(NPRS). - Secondary outcome measures: Anxiety and
depression (Hopkins Symptoms Checklist),
fear-avoidance beliefs questionnaire (FABQ), lumbar
ROM, patient satisfaction, sick-leave days, and care
seeking. - Short- and long-term follow-ups (after
treatment and 1 y follow-up).
Inclusion criteria:
Age of 18-65 y,
non-specific LBP
(chronic) > 3 mo,
primarily
localized from T12
to gluteal folds,
NPRS > 2/10 over
the past 14 d, OSW
score > 14%, and
pain aggravation
and relief with
postures,
movements, and
activities.
Subgroups:
-Cognitive and FCI
LBP, Cognitive and
passive ECI LBP,
Cognitive and
active ECI LBP ,
Cognitive and
lateral shift CI LBP,
Cognitive and
multidirectional
CI LBP , Cognitive
and FMI LBP ,
Cognitive and EMI
LBP , Cognitive and
decreased force
closure pelvic pain
, Cognitive and
increased force
closure pelvic pain
Sheeran et al.
(53), CS: OCS,
PEDro: 5/10
N = 58
Classification-specific postural intervention: Postural
training in accordance with LBP classification of the
patients. Education of patients with a flex pattern to
maintain lumbar relative ext and patients with an active
ext pattern to maintain relative lumbar flex (30-min
intervention with a total of 120 repetitions in standing
and sitting positions). Four weeks of home exs over 15
min with a total of 60 repetitions in standing and sitting
positions three times a day.
General postural intervention instructing all patients to
maintain the mid-position of lumbar spine between full
flex and full ext positions (30-min intervention with a
total of 120 repetitions in standing and sitting positions
and 4 wk of home exs over 15 min with a total of 60
repetitions in standing and sitting positions three times
a day).
- Primary outcome measure: Function (RMDQ) at 4 wk. -
Secondary outcome measures: Pain (VAS), spinal
repositioning sense, and trunk muscle activity during
sitting and standing positions. - Short-term follow-up
(after one-to-one intervention and at 4 wk follow-up).
Inclusion criteria:
Non-specific LBP
(chronic) for > 12
wk and
mechanical LBP in
the lumbar and
buttock regions.
Subgroups: -FCI,
-Active ECI
Henry et al. (49),
CS: TBC- MSI,
PEDro: 7/10
N = 124
- Ineligibles for stabilization exs received MSI treatment
matched to the subgroup, including education and exs
to correct movement patterns/postures and modify daily
activities. - Eligibles for stabilization exs received exs
involving repeated submaximal strengthening of trunk
muscles to improve the control and stability of the
trunk. - Eligibles for stabilization exs received matched
MSI treatment involving education and exs to correct the
movement patterns/postures and also modify daily
activities (one session weekly for 6 wk and daily home
exs).
Ineligibles for stabilization exs received unmatched
treatment, including repeated submaximal
strengthening of trunk muscles (one session weekly for 6
wk and daily home exs).
- Primary outcome measures: Function (OSW) and pain
(NPRS). - Secondary outcome measures: Function
(GCPS-DS), pain (GPCS- CPI), fear-avoidance beliefs (FABQ),
and health status questionnaire (SF-36). - Intermediate-
and long-term follow-ups (7 wk and 1y).
Inclusion criteria:
Age of 21 - 55 y, LBP
(chronic)≥ 12 mo
with/without
recurrences,
modified OSW
score≥ 19%
and/or a score of <
8 in at least one
activity from PSFS,
and current
employment or
active engagement
in daily activities.
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Subgroups based
on TBC: -Eligible
for stabilization,
Ineligible for
stabilization,
Subgroups based
on MSI: Rot, Rot
with flex, Rot with
ext
Saner et al. (51),
CS: OCS, PEDro:
5/10
N = 106
Movement control exs for specific subgroups consisting
of active exs including pain-provoking postures and
control over impaired movements. Special attention was
paid to functional restoration of impaired movements
(9-12 wk of clinic exs twice a wk for a duration of 30 min).
Home exs program was applied at least twice a wk for up
to 1 y after treatment.
General exs treatment to strengthen the lumbopelvic
region and leg muscles (9-12 wk of clinic exs twice a wk
for a duration of 30 min). A home exercise program was
applied for at least twice a wk for up to 1 y after treatment.
- Primary outcome measure: Function (PSFS). - Secondary
outcome measures: Pain (GCPS) and function (GCPS and
RMDQ). - Intermediate- and long-term follow-ups (after
treatment and at 6 mo and 1 y).
Inclusion criteria:
Age of 18-75 yrs,
non-specific LBP,
duration of LBP
(subacute and
chronic) > 6 wk,
no radiating
symptoms below
the knee, RMDQ≥
5, and history of
movement control
complaints along
with at least two
positive tests out
of six MCI tests.
Subgroups: -FCI
LBP, Passive ECI
LBP, Active ECI LBP,
Lateral shift CI LBP,
Multidirectional
CI LBP
Saner et al. (52),
CS: OCS, PEDro:
5/10
N = 106
Movement control treatment involving specific exs
designed to improve movement control, based on
classification subgroups (flex, ext, and multidirectional
impairment), postural awareness, and strengthening exs
after the control of painful movements (9 - 18 therapy
sessions over 12 wk, generally twice per wk).
General exs treatment including strength and endurance
training exs for the lumbopelvic regions and legs (9-18
therapy sessions over 12 wk, generally twice per wk).
- Primary outcome measure: Function (PSFS). - Secondary
outcome measures: Function (RMDQ). - Short-term
follow-up (after treatment)
Inclusion criteria:
Age of 18-75 yrs,
non-specific LBP
(subacute and
chronic) > 6 wk,
RMDQ≥ 5, and at
least two positive
tests out of six MCI
tests.
Subgroups: FCI
LBP, Passive ECI
LBP, Active ECI LBP,
Lateral shift CI LBP
, Multidirectional
CI LBP
Abbreviations: BDI, Beck Depression Inventory; CI, Control Impairment; CS, Classification scheme; d, day; DP, Directional preference; ECI, Extension Control Impairment; EMI, Extension Movement Impairment; Exs, Exercise; Ext, Exten-
sion; FABQ, Fear-Avoidance Beliefs Questionnaire; FCI, Flexion Control Impairment; Flex, Flexion; FMI, Flexion Movement Impairment; GPE, Global Perceived Effect; GCPS-DS, Graded Chronic Pain Scale-Disability Scale; GCPS-CPI, Graded
Chronic Pain Scale-Characteristic Pain Index; LBP, Low back pain; max, maximum; min, minute; MDT, Mechanical and Diagnosis Treatment; mo, month; MSI, Movement System Impairment; NPRS, Numerical Pain Rating Scale; OSC,
O’Sullivan Classification Scheme; OSW, Oswestry Disability Questionnaire; PEDro, PEDro scale score; PSFS, Patient-Specific Functional Scale; ROM, Range of motion; QTFQ, Quebec Task Force Questionnaire; RMDQ, Roland-Morris Disability
Questionnaire; Rot, Rotation; s, second; SF-36, 36-Item Short-Form Health Survey; SI, Sacroiliac; TBC, Treatment-Based Classification; VAS, Visual Analog Scale; wk, week; y, year.
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